14K
Downloads
67
Episodes
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
Episodes
![Amneal's Parkinson's pill approved, Novo Nordisk withdraws Wegovy approval expansion bid, FDA delays BeiGene Tevimbra decision [The good, the bad, the ugly]](https://pbcdn1.podbean.com/imglogo/image-logo/9655061/Security_14__hjvhxj_300x300.jpg){kind=logo}
Monday Aug 12, 2024
Monday Aug 12, 2024
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly.
Up this week:
The good — Amneal gets FDA nod for Parkinson’s pill
The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure
The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy